Diagnostic News and Research

RSS

CNIO researchers optimize new system capable of generating cellular model of Ewing sarcoma

A team from the Spanish National Cancer Research Centre (CNIO) has optimized a system capable of generating a cellular model of Ewing sarcoma.

10 May 2017

New findings pinpoint key feature of rare childhood disease that could help fast-track diagnosis

Australian scientists have shown, for the first time, that a family of untethered proteins builds up in the cells of children with a rare and serious genetic condition, known as mevalonate kinase deficiency (MKD).

10 May 2017

Scientists develop easy-to-use diagnostic test that could rapidly detect flu

The threat of a major flu pandemic is a perennial concern. Now scientists have developed a fast and easy-to-use point-of-care diagnostic test that could one day help doctors and hospitals head off the rapid spread of the flu.

10 May 2017

Sleep: perception and prioritization

The international survey on sleep that was recently conducted by Harris Poll on behalf of Philips, was conducted to support World Sleep Day and the activities across the globe carried out on this day were to increase awareness of the importance of sleep health.

From Philips Healthcare 10 May 2017

UK charity expects two million people to be diagnosed with cancer during next five years

Cancer Research UK expects around two million people to be diagnosed with cancer in the UK during the length of the next parliament according to new figures released today (Wednesday).

10 May 2017

Troponin elevations can occur in the absence of classic myocardial infarction, study shows

Elevated cardiac troponin, a diagnostic marker of damage to the heart, may occur even if a patient has not had a heart attack, according to a study published in JACC: Basic to Translational Science.

9 May 2017

Elekta Unity (MR/RT) featured in 20 abstracts at ESTRO

Advances in magnetic resonance radiation therapy (MR/RT) has the potential to transform accuracy, efficiency and clinical outcomes in radiation therapy.

9 May 2017

Elekta Unity introduced transformative magnetic resonance radiation therapy at ESTRO

Through intelligent and pioneering design, Elekta Unity (MR-linac) combines the best of both worlds to create a new paradigm for cancer care and provide extraordinary potential for ‘hard to treat’ cancers.

9 May 2017

Metabolite 'signatures' can accurately distinguish typhoid from other fever-inducing diseases

Researchers have identified a metabolite 'signature' that can accurately distinguish typhoid from other fever-inducing tropical diseases using patient blood samples.

9 May 2017

Despite availability of life-saving medicaiton, annual deaths due to fungal meningitis are still over 180,000

International HIV experts have reported approximately 250,000 fungal meningitis cases annually, in the AIDS report, sub-Saharan Africa contributing 73% of cases. Cryptococcus fungus causes fungal meningitis and usually affects individuals who are above 35 years old, affecting the tissues covering the brain and the spinal cord

8 May 2017

Large nuclear cardiology laboratory achieves dose reduction by 60%, study shows

A large nuclear cardiology laboratory has slashed its average radiation dose by 60% in eight years, according to new research presented today at ICNC 2017 and published in JACC: Cardiovascular Imaging.

8 May 2017

Study identifies potent molecular mechanism for insecticide resistance in sandfly species

A study led by LSTM identifies a potent molecular mechanism for insecticide resistance in the world's most medically-important sandfly species and develops DNA-diagnostics for monitoring future impact on visceral leishmaniasis control and elimination programs.

5 May 2017

Researchers find new way to make influenza visible to the naked eye

Researchers at the University of Notre Dame have discovered a way to make influenza visible to the naked eye, according to a new study in the Journal of the American Chemical Society.

5 May 2017

International consensus addresses research bottlenecks to diagnose rare genetic diseases

A worldwide consensus co-authored by more than 40 scientists sets out ways to address research bottlenecks as the international community strives to diagnose most rare genetic diseases by 2020.

4 May 2017

New research uncovers role of mysterious molecule in skin cancer

New research from Sanford Burnham Prebys Medical Discovery Institute (SBP) at Lake Nona uncovers the modus operandi of a mysterious molecule called SPRIGHTLY that has been previously implicated in colorectal cancer, breast cancer, and melanoma.

3 May 2017

Microarray technology company Arrayjet announces expansion plans

Arrayjet, the Midlothian-based microarray technology company has increased its staffing levels as it continues to expand and grow its international sales development pipeline, as many of the world’s leading university research and biomedical research institutes look to increase accuracy, speed and throughput of its drug discovery sampling using Arrayjet’s range of instrumentation.

3 May 2017

Myriad and Clovis ink deal on FDA-approved BRACAnalysis CDx test to identify patients with germline BRCA mutations for rucaparib treatment

Myriad Genetics, Inc. and Clovis Oncology, Inc. have announced a companion diagnostic collaboration to support a post-marketing regulatory commitment related to Clovis’ PARP inhibitor, Rubraca. Financial terms of the deal were not disclosed.

3 May 2017

New acoustic system from ruling out CAD presented at Swedish Society of Cardiology Meeting

In preparation for launch in the Swedish and Danish markets, Swedish/Danish Acarix AB’s (publ) (“Acarix”) CADScor®System will be on display at the Swedish Society of Cardiology spring meeting in Malmö, April 26-28. Delegates will have the opportunity to review first results from a study that was presented at the American College of Cardiology Annual Scientific Meeting held in Washington, March 17-19, 2017 showing that CADScor®System rules out CAD with 97% negative predictive value.

3 May 2017

Invivoscribe receives FDA approval for the LeukoStrat CDx FLT3 mutation assay companion diagnostic test for the selection of patients for Rydapt

Invivoscribe® Technologies Inc., a global company with more than 20 years of experience providing clonality and biomarker test solutions for the fields of oncology, personalized molecular diagnostics® and personalized molecular medicine®, today announces the premarket approval of LeukoStrat® CDx FLT3 Mutation Assay.

3 May 2017

Discovery of protein that causes liver disease brings hope for new treatments

In a world-first discovery, scientists at Sydney’s Westmead Institute for Medical Research have identified a protein that causes liver fibrosis (scarring), paving the way for new treatments for liver disease to be developed.

3 May 2017

Diagnostic News and Research

CNIO researchers optimize new system capable of generating cellular model of Ewing sarcoma

New findings pinpoint key feature of rare childhood disease that could help fast-track diagnosis

Scientists develop easy-to-use diagnostic test that could rapidly detect flu

Sleep: perception and prioritization

UK charity expects two million people to be diagnosed with cancer during next five years

Troponin elevations can occur in the absence of classic myocardial infarction, study shows

Elekta Unity (MR/RT) featured in 20 abstracts at ESTRO

Elekta Unity introduced transformative magnetic resonance radiation therapy at ESTRO

Metabolite 'signatures' can accurately distinguish typhoid from other fever-inducing diseases

Despite availability of life-saving medicaiton, annual deaths due to fungal meningitis are still over 180,000

Large nuclear cardiology laboratory achieves dose reduction by 60%, study shows

Study identifies potent molecular mechanism for insecticide resistance in sandfly species

Researchers find new way to make influenza visible to the naked eye

International consensus addresses research bottlenecks to diagnose rare genetic diseases

New research uncovers role of mysterious molecule in skin cancer

Microarray technology company Arrayjet announces expansion plans

Myriad and Clovis ink deal on FDA-approved BRACAnalysis CDx test to identify patients with germline BRCA mutations for rucaparib treatment

New acoustic system from ruling out CAD presented at Swedish Society of Cardiology Meeting

Invivoscribe receives FDA approval for the LeukoStrat CDx FLT3 mutation assay companion diagnostic test for the selection of patients for Rydapt

Discovery of protein that causes liver disease brings hope for new treatments

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News